TBC1D3K

gene
On this page

Summary

TBC1D3K (TBC1 domain family member 3K, HGNC:51245) is a protein-coding gene on chromosome 17q12, encoding TBC1 domain family member 3K (A0A087X1G2). Acts as a GTPase activating protein for RAB5.

Predicted to enable GTPase activator activity. Predicted to be located in plasma membrane.

Source: NCBI Gene 101060351 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_001291464

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:51245
Approved symbolTBC1D3K
NameTBC1 domain family member 3K
Location17q12
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000273513
Ensembl biotypeprotein_coding
Entrez101060351

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000620247, ENST00000859823

RefSeq mRNA: 1 — MANE Select: NM_001291464 NM_001291464

CCDS: CCDS74042

Canonical transcript exons

ENST00000620247 — 14 exons

ExonStartEnd
ENSE000037147463792599937926071
ENSE000037188623793235537932420
ENSE000037211623793335437933506
ENSE000037216633793045037930498
ENSE000037259453792908637929195
ENSE000037275983792864937928756
ENSE000037293423792812537928205
ENSE000037327923793288437932983
ENSE000037360593792441537924570
ENSE000037389813793104237931162
ENSE000037396663793187637931970
ENSE000037465063792760337927642
ENSE000037516533792623437926319
ENSE000039782243793448837935371

Expression profiles

Bgee: expression breadth ubiquitous, 102 present calls, max score 98.02.

Top tissues by expression

133 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047398.02gold quality
bone marrow cellCL:000209254.92silver quality
bone marrowUBERON:000237146.13gold quality
skeletal muscle tissueUBERON:000113444.16gold quality
muscle tissueUBERON:000238542.26gold quality
right uterine tubeUBERON:000130242.19silver quality
duodenumUBERON:000211442.03gold quality
lymph nodeUBERON:000002940.94gold quality
hindlimb stylopod muscleUBERON:000425239.32gold quality
bloodUBERON:000017838.70gold quality
ganglionic eminenceUBERON:000402337.82gold quality
smooth muscle tissueUBERON:000113537.77gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
fundus of stomachUBERON:000116036.24gold quality
testisUBERON:000047334.54gold quality
cortex of kidneyUBERON:000122534.52gold quality
right testisUBERON:000453434.39gold quality
right coronary arteryUBERON:000162534.35gold quality
left testisUBERON:000453333.43gold quality
tonsilUBERON:000237233.32gold quality
metanephros cortexUBERON:001053332.88gold quality
kidneyUBERON:000211332.40gold quality
liverUBERON:000210732.34gold quality
adult mammalian kidneyUBERON:000008232.05gold quality
muscle of legUBERON:000138331.57gold quality
primary visual cortexUBERON:000243631.16gold quality
sural nerveUBERON:001548830.93gold quality
gastrocnemiusUBERON:000138830.62gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.32

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

19 targeting TBC1D3K, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-335-3P99.9373.364958
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-449299.8768.253611
HSA-MIR-130B-5P99.8368.501888
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-7110-5P99.8067.841712
HSA-MIR-1213099.7565.47452
HSA-MIR-5584-5P99.4968.222814
HSA-MIR-450599.2767.812678
HSA-MIR-3940-5P99.1465.26493
HSA-MIR-450799.1465.27515
HSA-MIR-42198.9067.041883
HSA-MIR-7155-5P98.6566.141290
HSA-MIR-806098.6166.931187
HSA-MIR-5585-5P97.9568.801024
HSA-MIR-3135A96.4165.30494
HSA-MIR-548AD-3P94.3966.04350

Cross-species orthologs

0 orthologs

Paralogs (45): RABGAP1 (ENSG00000011454), TBC1D22A (ENSG00000054611), TBC1D22B (ENSG00000065491), TBC1D1 (ENSG00000065882), EVI5 (ENSG00000067208), TBC1D25 (ENSG00000068354), TBC1D2 (ENSG00000095383), TBC1D10A (ENSG00000099992), SGSM3 (ENSG00000100359), TBC1D17 (ENSG00000104946), TBC1D13 (ENSG00000107021), TBC1D12 (ENSG00000108239), TBC1D9 (ENSG00000109436), TBC1D30 (ENSG00000111490), TBC1D15 (ENSG00000121749), TBC1D5 (ENSG00000131374), TBC1D14 (ENSG00000132405), TBC1D8B (ENSG00000133138), TBC1D4 (ENSG00000136111), GRTP1 (ENSG00000139835), SGSM2 (ENSG00000141258), EVI5L (ENSG00000142459), TBCK (ENSG00000145348), USP6NL (ENSG00000148429), RABGAP1L (ENSG00000152061), SGSM1 (ENSG00000167037), TBC1D21 (ENSG00000167139), TBC1D2B (ENSG00000167202), TBC1D16 (ENSG00000167291), TBC1D10B (ENSG00000169221), TBC1D10C (ENSG00000175463), TBC1D28 (ENSG00000189375), TBC1D9B (ENSG00000197226), TBC1D8 (ENSG00000204634), TBC1D26 (ENSG00000214946), TBC1D3G (ENSG00000260287), TBC1D3H (ENSG00000274226), TBC1D3D (ENSG00000274419), TBC1D3L (ENSG00000274512), TBC1D3 (ENSG00000274611)

Protein

Protein identifiers

TBC1 domain family member 3KA0A087X1G2 (reviewed: A0A087X1G2)

All UniProt accessions (1): A0A087X1G2

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a GTPase activating protein for RAB5. Does not act on RAB4 or RAB11.

Subcellular location. Cell membrane.

Post-translational modifications. Ubiquitinated by a CUL7-based E3 ligase, which leads to proteasomal degradation. Palmitoylation is required for membrane localization and protects TBC1D3 from ubiquitination.

Miscellaneous. TBC1D3 is encoded by a collection of very similar paralogs with multiple copies of each paralog, some human genomes encoding well over 50 copies depending on ethnic origin of the donor.

RefSeq proteins (1): NP_001278393* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000195Rab-GAP-TBC_domDomain
IPR035969Rab-GAP_TBC_sfHomologous_superfamily
IPR050302Rab_GAP_TBC_domainFamily

Pfam: PF00566

UniProt features (6 total): lipid moiety-binding region 2, chain 1, domain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A0A087X1G2-F160.960.25

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 318, 325

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 11 (showing top): GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, MIR335_3P, MIR5585_5P, chr17q12, JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP, GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY, WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME, GOCC_ENDOSOME, GOMF_GTPASE_ACTIVATOR_ACTIVITY

GO Biological Process (0):

GO Molecular Function (1): GTPase activator activity (GO:0005096)

GO Cellular Component (3): endosome (GO:0005768), plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
GTPase activity1
enzyme activator activity1
GTPase regulator activity1
endomembrane system1
cytoplasmic vesicle1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

134 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TBC1D3KKRTAP2-2Q9BYT5590
TBC1D3KERLNP0DI80571
TBC1D3KC17orf50Q8WW18570
TBC1D3KSCGB1C2P0DMR2542
TBC1D3KKRTAP9-7A8MTY7526
TBC1D3KCDRT15L2A8MXV6506
TBC1D3KMTRNR2L1P0CJ68506
TBC1D3KCFAP97D1B2RV13446
TBC1D3KSPMAP1A8MV24434
TBC1D3KKRTAP9-8Q9BYQ0432
TBC1D3KSPEM2Q0P670419
TBC1D3KOR1E2P47887418
TBC1D3KCCDC144AA2RUR9402
TBC1D3KSLC35G6P0C7Q6399
TBC1D3KSLC35G3Q8N808398

IntAct

0 interactions, top by confidence:

BioGRID (5): TBC1D3K (Two-hybrid), TBC1D3K (Two-hybrid), TBC1D3K (Negative Genetic), TBC1D3K (Negative Genetic), TBC1D3K (Negative Genetic)

ESM2 similar proteins: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A6NDS4, A6NER0, A6QPT6, B9A6J9, M3WHG5, O14771, O15482, O15553, O19110, O76081, P0C7X1, P0C7X3, P0C7X4, P35125, P48778, P48967, P79209, Q13670, Q15697, Q2TBC4, Q3T191, Q3UZD7, Q4R2Z8, Q5DRQ5, Q5SSQ6, Q5XFX8, Q69ZB3, Q6DHY5, Q6IPX1, Q6ZMN8, Q8BLR5, Q8BWA8, Q8IYF1, Q8IZP1, Q8JZW5, Q8N7G0

Diamond homologs: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A2AWA9, A6H6A9, A6NDS4, A6NER0, B9A6J9, H2KZZ6, P0C7X1, P35125, Q2M2D7, Q5RAN1, Q5SVR0, Q66K14, Q6DHY5, Q6IPX1, Q80XC3, Q86UD7, Q8IZP1, Q92738, Q9UFV1, Q9Y3P9, A3KGB4, A6QP29, B0R0W9, B7ZAP0, O60343, O60447, O95759, O97790, P58802, P97366, Q0IIM8, Q10496, Q12317, Q12344, Q28CB1, Q3UYK3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2467 predictions. Top by Δscore:

VariantEffectΔscore
17:37928647:A:AGacceptor_gain1.0000
17:37928648:G:GAacceptor_gain1.0000
17:37929196:G:GGdonor_gain1.0000
17:37932979:GCAGA:Gdonor_gain1.0000
17:37932982:GA:Gdonor_gain1.0000
17:37932982:GAGT:Gdonor_loss1.0000
17:37932983:AGTA:Adonor_loss1.0000
17:37932984:G:GGdonor_gain1.0000
17:37932984:GTAA:Gdonor_loss1.0000
17:37934487:GCC:Gacceptor_gain1.0000
17:37924570:GGTG:Gdonor_loss0.9900
17:37924571:G:Cdonor_loss0.9900
17:37926315:GTACA:Gdonor_gain0.9900
17:37926320:G:GGdonor_gain0.9900
17:37927601:A:AGacceptor_gain0.9900
17:37927602:G:GGacceptor_gain0.9900
17:37928644:CACA:Cacceptor_loss0.9900
17:37928645:ACAGC:Aacceptor_loss0.9900
17:37928646:CAGCT:Cacceptor_loss0.9900
17:37928647:A:ATacceptor_loss0.9900
17:37928648:GCT:Gacceptor_gain0.9900
17:37928648:GCTC:Gacceptor_gain0.9900
17:37928752:ACCAG:Adonor_loss0.9900
17:37928753:CCAG:Cdonor_loss0.9900
17:37928754:CAG:Cdonor_loss0.9900
17:37928755:AGGT:Adonor_loss0.9900
17:37928756:GGTA:Gdonor_loss0.9900
17:37928757:GT:Gdonor_loss0.9900
17:37928758:T:Adonor_loss0.9900
17:37929070:T:TAacceptor_gain0.9900

AlphaMissense

3579 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:37931114:T:CF207L0.981
17:37931116:C:AF207L0.981
17:37931116:C:GF207L0.981
17:37932911:T:AW286R0.932
17:37932911:T:CW286R0.932
17:37928700:T:AW111R0.929
17:37928700:T:CW111R0.929
17:37931117:T:AW208R0.901
17:37931117:T:CW208R0.901
17:37929094:G:CK132N0.899
17:37929094:G:TK132N0.899
17:37931115:T:CF207S0.895
17:37928158:T:AW78R0.894
17:37928158:T:CW78R0.894
17:37928702:G:CW111C0.889
17:37928702:G:TW111C0.889
17:37931119:G:CW208C0.888
17:37931119:G:TW208C0.888
17:37931111:G:CA206P0.879
17:37929173:T:CF159L0.877
17:37929175:C:AF159L0.877
17:37929175:C:GF159L0.877
17:37928160:G:CW78C0.869
17:37928160:G:TW78C0.869
17:37928752:A:CY128S0.862
17:37928157:G:CK77N0.860
17:37928157:G:TK77N0.860
17:37928181:G:CW85C0.854
17:37928181:G:TW85C0.854
17:37928751:T:GY128D0.854

dbSNP variants (sampled 300 via entrez): RS1157054647 (17:37930915 C>T), RS1157917450 (17:37932837 C>A,T), RS1158264303 (17:37921811 C>A), RS1158392012 (17:37930240 G>T), RS1158401122 (17:37924612 G>A), RS1158497970 (17:37923616 C>G,T), RS1159100165 (17:37930891 T>A,C), RS1159153691 (17:37923200 G>C), RS1159198773 (17:37929448 A>G), RS1159379071 (17:37922397 T>C), RS1160546016 (17:37933463 T>C), RS1161108855 (17:37921640 T>A), RS1161436582 (17:37923291 G>C), RS1162485563 (17:37924358 GA>G), RS1162903966 (17:37929646 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aincreases expression1
tri-o-cresyl phosphateincreases expression1
2-palmitoylglycerolincreases expression1
Smokedecreases expression1
Tretinoinincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.